| 4 | Phosphotransferases (Kinase)IBA
04/2024
-
01/2017 |
| 3 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2023
-
10/2009 |
| 2 | Proteins (Proteins, Gene)FDA Link
04/2024
-
01/2023 |
| 2 | Imatinib Mesylate (Gleevec)FDA Link
01/2023
-
01/2017 |
| 2 | CateninsIBA
01/2022
-
09/2013 |
| 1 | LigandsIBA
04/2024 |
| 1 | tyrosine receptor (receptor, tyrosine)IBA
04/2024 |
| 1 | N- (pyridine- 3- ylmethyl)- 5- (7- hydroxy- 2,6,8- trimethyl- 1,2,4a,5,6,7,8,8a- octahydronaphthalene- 1- yl)- 2- methylpenta- 2,4- dienamideIBA
04/2024 |
| 1 | Brefeldin AIBA
04/2024 |
| 1 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 |
| 1 | Protein Kinase D2IBA
01/2023 |
| 1 | Sunitinib (Sutent)FDA Link
01/2023 |
| 1 | KynurenineIBA
01/2022 |
| 1 | PolyaminesIBA
01/2021 |
| 1 | Dextran SulfateIBA
01/2021 |
| 1 | Tyrosine Kinase InhibitorsIBA
01/2020 |
| 1 | TAS-116IBA
01/2020 |
| 1 | Mechanistic Target of Rapamycin Complex 1IBA
01/2019 |
| 1 | LipidsIBA
01/2019 |
| 1 | Interleukin-3 (Interleukin 3)IBA
01/2017 |
| 1 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2017 |
| 1 | TOR Serine-Threonine KinasesIBA
07/2015 |
| 1 | ErbB Receptors (EGF Receptor)IBA
07/2015 |
| 1 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2015 |
| 1 | Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
07/2015 |
| 1 | Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2015 |
| 1 | Histone Deacetylases (Histone Deacetylase)IBA
03/2015 |
| 1 | Volatile Fatty AcidsIBA
12/2013 |
| 1 | Butyrates (Butyrate)IBA
12/2013 |
| 1 | Cadherins (E-Cadherin)IBA
09/2013 |
| 1 | CytokinesIBA
01/2013 |
| 1 | Notch ReceptorsIBA
03/2012 |
| 1 | Transcription Factors (Transcription Factor)IBA
03/2012 |
| 1 | Anti-Bacterial Agents (Antibiotics)IBA
03/2012 |
| 1 | DNA (Deoxyribonucleic Acid)IBA
09/2009 |